2013-02-22 13:53:52 - SADIF-Investment Analytics has applied its StockMarks™ stock-rating system to Europlasma SA and produced a Rating Update Report, rating the company's attractiveness to long-term investors.
Ilhavo, Portugal – SADIF Investment Analytics, announces a new Rating Update Report covering Europlasma SA (ALEUP). The report uses SADIF's powerful StockMarks™ stock rating system and contains important analysis for any current or potential Europlasma SA investor.
Report Summary: Europlasma SA is an above average quality company with a positive outlook. Europlasma SA has strong business growth and is run by mediocre management. The trend in Europlasma SA fair value exchange rate against its closest rated-competitor, Demos, has been stable over the past 2 weeks. When compared to its closest competitor, Europlasma SA shows similar overvaluation and is equally likely to outperform the market.
The 3-page report breaks down the Total StockMark into its three components – business, management and price, performing
an in-depth analysis of Europlasma SA for long-term investors.
The report has been distributed to Thomson Reuters. It is available in Investext from multiple professional platforms including Thomson Research, Thomson ONE Banker, DIALOG/INTELLISCOPE, Thomson Gale, West Services, Advisen, Alacra-Datadownlink, Factiva, INTERNET SECURITIES and LEXIS/NEXIS or directly from SADIF-Investment Analytics at:
About SADIF-Investment Analytics:
SADIF-Investment Analytics is an independent investment research company covering sixteen different markets and over 12,000 companies. The StockMarks™ system is based on proven investment principles and is designed to drive long-term shareholder returns.